安南身心科張俊鴻主任
BrainsWay Deep TMS 為以色列公司
目前TMS已經有超過八種
"In January 2013, the FDA approved Deep TMS therapy developed by BrainsWay. Deep TMS therapy penetrates a deeper and boarder area of the brain than traditional TMS treatment. It is used for the treatment of depressive in adult patients suffering from Major Depressive Disorder, who have failed to achieve satisfactory improvement through various antidepressant medication treatments. In August of 2018, BrainsWay became the only TMS provider FDA-cleared for treatment of OCD using Deep TMS therapy. It has been used to treat depression in several other countries and is currently under investigation for other conditions." (https://www.clinicaltmssociety.org/tms/devices)
